Frontlight ResearchEarly access
Trial site
Byers Eye Institute, Stanford University
- 4closed trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration2 trials
- Graves' disease1 trial
- Melanoma1 trial
- Phase
- Phase 32 trials
- Phase 21 trial
- Status
- Completed4 trials
- Lead sponsor
- Apellis Pharmaceuticals, Inc.1 trial
- Immunocore Ltd1 trial
- Science Corporation1 trial
- Viridian Therapeutics, Inc.1 trial
Closed trials
Completed
Completed
Completed
Completed
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
Site data: ClinicalTrials.govUpdated 13 Nov 2026